SlideShare a Scribd company logo
Tello-Bernabé et al. Implementation Science 2011, 6:123
http://www.implementationscience.com/content/6/1/123
                                                                                                            Implementation
                                                                                                               Science




 STUDY PROTOCOL                                                                                                                               Open Access

Effectiveness of a clinical practice guideline
implementation strategy for patients with anxiety
disorders in primary care: cluster randomized trial
Eugenia Tello-Bernabé1*, Teresa Sanz-Cuesta2, Isabel del Cura-González2, María L de Santiago-Hernando3,
Montserrat Jurado-Sueiro3, Mercedes Fernández-Girón4, Francisca García-de Blas5, Higinio Pensado-Freire6,
Francisco Góngora-Maldonado7, María J de la Puente-Chamorro6, Carmen Rodríguez-Pasamontes8 and
Susana Martín-Iglesias9


  Abstract
  Background: Anxiety is a common mental health problem seen in primary care. However, its management in
  clinical practice varies greatly. Clinical practice guidelines (CPGs) have the potential to reduce variations and
  improve the care received by patients by promoting interventions of proven benefit. However, uptake and
  adherence to their recommendations can be low.
  Method/design: This study involves a community based on cluster randomized trial in primary healthcare centres
  in the Madrid Region (Spain). The project aims to determine whether the use of implementation strategy
  (including training session, information, opinion leader, reminders, audit, and feed-back) of CPG for patients with
  anxiety disorders in primary care is more effective than usual diffusion.
  The number of patients required is 296 (148 in each arm), all older than 18 years and diagnosed with generalized
  anxiety disorder, panic disorder, and panic attacks by the Diagnostic and Statistical Manual of Mental Disorders-IV
  (DSM-IV). They are chosen by consecutive sampling.
  The main outcome variable is the change in two or more points into Goldberg anxiety scale at six and twelve
  months. Secondary outcome variables include quality of life (EuroQol 5D), and degree of compliance with the CPG
  recommendations on treatment, information, and referrals to mental health services. Main effectiveness will be
  analyzed by comparing the patients percentage improvement on the Goldberg scale between the intervention
  group and the control group. Logistic regression with random effects will be used to adjust for prognostic factors.
  Confounding factors or factors that might alter the effect recorded will be taken into account in this analysis.
  Discussion: There is a need to identify effective implementation strategies for CPG for the management of anxiety
  disorders present in primary care. Ensuring the appropriate uptake of guideline recommendations can reduce
  clinical variation and improve the care patients receive.
  Trial registration: ISRCTN: ISRCTN83365316


Background                                                                           of unpleasantness and/or somatic symptoms of tension.
Normal and pathological anxiety                                                      This feeling is normal in the face of certain day-to-day
Anxiety is a common mental health problem seen in                                    stressing situations. When it exceeds a certain intensity
primary care. Anxiety can be defined as an anticipation                              or overwhelms a person’s adaptive capacity, anxiety
of future harm or misfortune, accompanied by a feeling                               becomes pathological. Anxiety disorders are a group of
                                                                                     illnesses characterized by the presence of worry, excess
* Correspondence: mtello.gapm09@salud.madrid.org
                                                                                     of fear or dread, tension, or activation that causes a
1
 Centro de Salud El Naranjo. Gerencia Atención Primaria. Servicio Madrileño          notable uneasiness or a clinically significant deteriora-
de Salud. Spain                                                                      tion of an individual’s activity [1].
Full list of author information is available at the end of the article

                                       © 2011 Tello-Bernabé et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
                                       Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
                                       reproduction in any medium, provided the original work is properly cited.
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                          Page 2 of 9
http://www.implementationscience.com/content/6/1/123




   The causes of anxiety disorders are not entirely              The scope of the CPG covers the diagnosis and man-
known, but biological factors, as well as environmental        agement of adult patients with generalized anxiety disor-
and psychosocial ones, are involved [2-4]. Some authors        ders (GAD) and panic disorder (PD), with or without
say that it is the interaction of multiple determining fac-    agoraphobia, in the context of primary care.
tors that favours the appearance of these anxiety disor-         Two aspects of this CPG development are worth not-
ders [5]. In addition, co-morbidity with other mental          ing. The first is the involvement of patients with anxiety
disorders, such as mood disorders, is very common              disorders in all phases of the development process. The
[3-6].                                                         second is that the CPG includes interventions that can
   The proper diagnosis, treatment, and, in those cases        be carried out by the various professionals working in
where necessary, appropriate referral of anxiety disor-        primary care. These interventions are carried out at the
ders to mental health services, is fundamental for effec-      primary healthcare centers, mainly by nursing and/or
tive clinical management [7,8].                                social workers [19]. Likewise, it is worth noting the low
                                                               utilization of psychological interventions of proven effec-
Anxiety as a health problem                                    tiveness [20]. Our group has carried out a study that
The prevalence of anxiety disorders varies depending on        focuses on the evaluation of the effectiveness of the
different epidemiological studies, with prevalence-year        intervention groups directed by nurses in patients with
and prevalence-life being set at between 10.6% and             anxiety in primary care [21].
16.6% [9]. Data for Spain from the European Study of             The Goldberg Anxiety and Depression Scale (GADS)
the Epidemiology of Mental Disorders (ESEMeD) esti-            has been included in the guideline to evaluate the
mate a prevalence-year of 5.1% [10,11]. Mental disorders       changes obtained by the various interventions and as a
represent a burden for individuals, as well as for families    way to provide key questions to guide the clinical inter-
and the community. In the case of the community of             view. This scale has been chosen because it is brief and
Madrid, neuropsychiatric illnesses are confirmed as the        easy to manage and interpret [22-24]. The Spanish ver-
first cause of adjusted years of life for incapacity [12].     sion has demonstrated its reliability and validity within
   According to the World Health Organization’s report         the ambit of primary care, and it has the right sensitivity
on mental health, 20% of all patients attended by pri-         (83.1%), specificity (81.8%), and positive predictive value
mary care professionals suffer one or more mental dis-         (95.3%) [25].
orders. This report recommends that management and
treatment be performed as far as possible in primary           Strategies to implement CPGs
care so as to facilitate access to services for the greatest   CPGs will only be useful for professionals and patients if
number of people possible [13].                                their recommendations are incorporated to regular clini-
                                                               cal practice. Achieving this is a complex process in
Clinical practice guidelines (CPGs) as a tool for the          which several factors play a role [26,27].
management of anxiety disorders in primary care                  To increase the use of the guideline, its distribution
The diagnostic and therapeutic approach to these disor-        and implementation strategy must be planned very care-
ders varies widely. Primary care professionals have dif-       fully. As a first step, the identification of the barriers
ferent grades of training in the area of mental health, in     and facilitating factors, adapting all strategies to the set-
psychiatric interview skills, as well as in psychological      ting in which the CPGs will be used, is fundamental
intervention techniques [14-16].                               [28-30].
  A study in the United States between 1985 and 1998             Several CPGs implementation strategies have demon-
described an increase in the use of psychopharmaceuti-         strated their effectiveness. Some authors group these
cal medication in primary care visits (38.7% compared          interventions depending on whom they are addressed
with 54.6%) while, at the same time, it showed a con-          to: physicians and patients, communities or the general
stant drop in the use of psychological interventions           population, or health centres and/or health systems [31].
(6.8% to 2%) in the treatment of anxiety disorders [17].         The Cochrane EPOC (Effective Practice and Organiza-
  CPGs are a good tool to reduce this variability and          tion of Care) group proposes to classify interventions
improve evidence informed in the clinical decision-mak-        into four categories: professional interventions (such as
ing. In Spain, the Ministry of Health and Social Policy        distribution of educational materials or educational
has put into effect the ‘Guiasalud’ project [18] to draft      meetings); financial interventions (such as fee-for-service
CPGs. In the framework of this project, the Clinical           or prospective payment); organisational interventions
Practice Guideline for the Approach to Anxiety Disorders       (such as creation of clinical multidisciplinary teams) and
in Primary Care has been drafted in coordination with          regulatory interventions (any intervention that aims to
the Technologies Assessment Unit of the Agencia Lain           change health services delivery or costs by regulation or
Entralgo [19].                                                 law) [32].
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                        Page 3 of 9
http://www.implementationscience.com/content/6/1/123




  The Grimshaw [33]et al. review evaluates the effec-          information proposed in the guideline (oral or written)
tiveness and cost of different clinical practice guideline     about their disorder.
dissemination-implementation organizational strategies.          3. Evaluate the effectiveness of a CPG implementation
This study takes into account the impact on profes-            strategy for the management of patients with anxiety
sionals as well as on patients. It includes 235 studies        disorders compared with the regular strategy, measured
(between 1966 and 1998) and 309 comparisons. Among             as the degree of suitability of referral to mental health
the results, it is worth noting that most implementation       services, based criteria established in the guideline.
strategies improved adherence to CPGs. Simple strate-            4. Describe the professionals’ opinion about the use-
gies, such as reminders, increase adherence by 14.1%.          fulness of the CPG.
The distribution of educational materials improves this          5. Evaluate the effectiveness of a CPG implementation
by 8.1%. Educational programmes, almost always as              strategy for the management of patients with anxiety
components of more complex interventions, improved             disorders compared with the regular strategy measured
practice by 6%, and audits and feedback by 7%. The             as a change in the patient’s quality of life.
complexity of the strategies and the mixture of interven-
tions did not improve results. In their conclusions, it is     Methods/design
noted that there is little evidence about which strategies     Design of the study
can be more effective in each situation. The authors           This study is a two-year community, parallel clinical
consider that there is a need to develop and validate          trial, randomised by clusters, that compares two differ-
theoretical models for behavioural change, as well as to       ent CPG implementation strategies. The intervention
investigate the efficiency of the strategies in the presence   will be made on health professionals (physicians, nurses,
of different barriers and factors that can modify              and social workers) of primary healthcare centres
effectiveness.                                                 (PHCC) in the region of Madrid, Spain. The randomiza-
  We consider it fundamental to put into effect organi-        tion units will be PHCCs (clusters). The units of analysis
zational strategies that will enable us to use the guide-      are patients of health professionals (individual level) of
line and apply its recommendations, as well as to              the PHCCs participating in the study (as a control or
measure and evaluate the impact that implementation of         intervention) according to the CONSORT checklist
the CPGs will have on professionals modifying their            (additional file 1).
practices, and improving outcomes for patients [34,35].
  There are two reasons for using cluster randomised           Subjects of the study
trials design: to evaluate the group effect of an interven-    Subjects older than 18 years of age, who visit primary
tion; and to avoid ‘contamination’ across interventions        care because of symptoms compatible with anxiety dis-
when trial participants are managed within the same            orders at PHCCs in the region of Madrid, and those
setting.                                                       who have been diagnosed with anxiety disorders accord-
                                                               ing to Statistical Manual of Mental Disorders-IV (DSM-
Main objective                                                 IV) criteria [1].
The aim of the present work is to determine whether
the use of a CPG implementation strategy (including            Inclusion criteria
training session, information, opinion leader, reminders,      Agree to participate in the study and written informed
audit, and feed-back) for patients with anxiety disorders      consent.
in primary care is more effective than usual diffusion in
improving the score of the Goldberg anxiety scale at six       Exclusion criteria
and twelve months.                                             1. Subjects diagnosed with anxiety for post-traumatic
                                                               stress, acute stress disorders, anxiety disorders induced
Secondary objectives                                           by substances, organic anxiety disorders.
1. Evaluate the effectiveness of a CPG implementation            2. Subjects who cannot read or understand Spanish.
strategy for the management of patients with anxiety             3. Subjects who will not reside in the basic area in the
disorders compared with the regular strategy, measured         year following their inclusion in the study.
as the degree of suitability of the treatments (psycholo-        4. Immobilized or institutionalized patients.
gical, pharmacological, et al.) received by patients.
  2. Evaluate the effectiveness of a CPG implementation        Sample size
strategy for the management of patients with anxiety           Method of calculation
disorders compared with the regular strategy, measured         For an alpha of 0,05, a power of 80% and in order to
as the percentage of patients who have received the            detect a decrease in the Goldberg Scale (two or more
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                       Page 4 of 9
http://www.implementationscience.com/content/6/1/123




points) of 20% in the intervention group, the overall        Intervention group
simple size required 206 patients (103 in each arm of        The intervention, through the different strategies, has
the study). Because randomisation was by cluster, the        been designed to allow professionals to understand the
sample size had to be larger than if simple randomisa-       guideline thoroughly, and also to implement its
tion had been performed, in order to take into account       recommendations.
the design effect (DE). The DE was calculated as follows:      1. The CPG will be searchable on the intranet cor-
DE = 1 + (nc - 1) * ICC (where nc is the mean number         porative system.
of individuals in the cluster, and ICC the intracluster        2. Centralized area clinical session with a duration of
correlation coefficient) [36]. The ICC in the present        60 minutes, to which each one of the professionals from
work was deemed to be 0.01. The mean cluster size was        each of the 16 PHCCs will be invited and where the
assumed to be 20 patients. Given these assumptions,          CPG will be presented.
and expecting a 20% loss rate, the final sample size           3. Information: Presentation of CPG in the PHCCs.
required was 296 patients (148 in each arm).                   4. Training: two sessions with a duration of 60 min-
                                                             utes, imparted at PHCCs by the researchers.
Randomisation                                                  5. Information and training to physicians, nurses, and
Unit of allocation                                           social workers with the following contents:
Allocation will be performed by clusters, the PHCC
being the randomisation unit. This will minimise possi-         a. Information and diagnosis: This would focus on
ble contamination effects between professionals.                the questions in the guideline that approach the
                                                                definition of anxiety and its differentiation as a
Sequence generation                                             symptom and as a disorder. It would approach the
The 16 PHCCs will be assigned to the intervention or            semi-structured interview at the visit with an active
the control group following a simple, computer-gener-           methodology (roll-playing, et al.).
ated random sequence (EPIDAT 3.1).                              b. Pharmacological treatment and algorithms.
                                                                c. Non-pharmacological treatment: Group techni-
Concealment of allocation                                       ques (see table 2), bibliotherapy and medicinal herbs.
Randomization will be performed centrally by a
researcher not involved in the study, and who was blind        2. Opinion head/leader: a professional designated at
to the identity of the PHCCs.                                each centre (physician, nurse or social worker).
  Consecutive patients will be chosen to minimise the          3. Structured training: Training of nurses and social
risk of bias in their selection. During consultations,       workers to carry out anxiety disorder groups of six to
patients will be informed about the study and asked          eight sessions.
whether they would like to take part in it. Those who          4. Reminders: Reminders will be sent in the form of
accept will be asked to complete a signed consent form.      letters or electronic flashes or systems of alert about
Checks will be made to ensure they met all inclusion         publications.
criteria, but no exclusion criterion.                          5. Audit: The results will be audited and will be
                                                             returned to the PHCCs through the local leader.
Masking
In the study, the patients, the professionals implement-     Patient variables (individual level)
ing the interventions, and those assessing the outcomes      Variables to measure health outcomes
will not be blinded to the assignment group. However,        1. Degree of anxiety, measured by the Goldberg anxiety
analysis data will be performed by independent profes-       subscale. The decrease in the score by two or more
sionals blinded to the assignment group.                     points compared with baseline score will be evaluated at
                                                             six and twelve months.
Intervention (see Table 1)                                     2. Quality of life measured by means of the EuroQol
Control group                                                5D questionnaire. The quality of life will be evaluated at
1. The CPGs will be searchable on the intranet corpora-      baseline, six months and twelve months.
tive system.
   2. Centralized area clinical session with a duration of   Clinical variables recorded to check the degree of
60 minutes, to which each one of the professionals from      suitability of the guideline recommendations
each of the 16 health centres will be invited, and where     Previous episodes and treatment, diagnosis and current
the CPGs will be presented.                                  therapeutic plan, and reason for referral to mental health.
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                                              Page 5 of 9
http://www.implementationscience.com/content/6/1/123




Table 1 Interventions to professionals in both groups
Step 1                      Centralized clinical session for the 16 PHCCs in which the GPC will be presented. Website ‘Guiasalud’.
                            Invitation to participate.
Step 2                                                              Primary Healthcare Centre RANDOMIZATION
Step 3                      Intervention group                                                                       Control group
                            IMPLEMENTATION STRATEGIES:                                                               Regular care
                            - Information and training about diagnosis and therapeutic plan
                            - Election of opinion leader
                            - Information and training structured to create anxiety disorder groups
Step 4 (after visit 2)      IMPLEMENTATION STRATEGIES:                                                               Regular care
                            - Audit and feedback
                            - Reminders
Step 5 (after visit 3)      IMPLEMENTATION STRATEGIES:                                                               Regular care
                            - Audit and feedback
                            - Reminders



Table 2 Group intervention in anxiety
First session
                                Presentation of the group
                                General introduction to program
                                Educational component:
                                     • What is the response to anxiety?
                                     • Why does it happen in daily life?
                                     • Is recovery possible?
                                     • What is the recovery process?
                                The role of lifestyle in the response to anxiety (Part 1):
                                     • What do we do to take care of ourselves?
                                     • How lifestyle influences.
                                     • Introduction to relaxation and breathing.
Second session
                                Introduction, we clarify doubts.
                                The interpretation of body sensations. What is an anxiety crisis? Why does it appear?
                                Understand the role thoughts-behaviour-emotions play in the maintenance of the problem.
                                The role of lifestyle in the response to anxiety (Part 2):
                                     • Physical exercise
                                     • We learn to breath (control of breathing)
                                     • Relaxation training
Third session
                                We review relaxation training execution and follow up with respect to exercise.
                                The role of lifestyle in the response to anxiety (Part 3):
                                     • Eating/consumption toxics/stimulants
                                     • Control of breathing
                                     • Relaxation training
Fourth session
                                We review relaxation training execution and follow up with respect to exercise.
                                The role of lifestyle in the response to anxiety (Part 4):
                                     • Pace activity/rest (sleep)
                                     • Control of breathing
                                     • Relaxation training
Fifth session
                                We review control of breathing and relaxation training execution.
Sixth session
                                We review control of breathing and relaxation training execution.
                                Using what we learned to face future changes: integrating vision to remember what we learned.
                                Depending on availability, the group intervention can be extended to eight sessions.
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                         Page 6 of 9
http://www.implementationscience.com/content/6/1/123




Sociodemographic variables recorded                           Ethical considerations
Age, gender, nationality, time of residence in Spain, and     The study protocol was approved by the Research Ethics
employment status.                                            Committee on 29 April 2010 and met all good clinical
                                                              practice demands right. This study has been funded by
Variables recorded for family physicians (cluster level)      the Spanish Ministry of Science and Innovation via the
Age, gender, years of professional activity, training in      Instituto de Salud Carlos III (PI09/90304). The trial was
interview skills, training in psychological intervention      registered with Current Controlled Trials, number
techniques, average number of patients attended in            ISRCTN83365316.
three months, and evaluation about usefulness of the            [http://www.controlled-trials.com/ISRCTN83365316]
guide and modification of its clinical practice.
                                                              Discussion
Data collection method                                        The proposed implementation strategy should have
Professionals                                                 impact at four levels: increasing the knowledge of clinical
Data will be collected by telephone interview by a mem-       physicians and patients; changing attitudes; changing the
ber of the research team before randomisation. All data       habits and behaviour of professionals in their clinical prac-
will be collected except the number of patients visited,      tice, while taking into account the patient’s preferences, as
which will be taken from the health information system.       well as administrative and economic influences; and modi-
Opinion will be collected at the end of the study.            fying results, which means improving the quality of care
                                                              and, finally, the health of the population by following CPG
Patients                                                      recommendations [37,38]. In this study, we will focus on
The clinical interview will be used and the data will be      checking the degree of suitability of the guideline recom-
recorded in an electronic data collection log especially      mendations (in terms of treatment, referral to mental
designed for this study. The different variables will be      health services, and information to the patient) in the clin-
collected over four follow-up visits: baseline, three, six,   ical practice. We will also check if health outcomes (anxi-
and twelve months. The Figure 1 shows the flowchart of        ety and quality of life) are improving.
the study.                                                       If the intervention proposed is effective, it could be
                                                              generalized to other common problems present in pri-
Statistical analysis                                          mary care. The findings of the study can also inform a
This will be based on the principle of intention to treat.    future updates of the guideline. The ‘Guiasalud’ project
The use of the design by clusters chosen will be taken        includes a methodological manual for GPCs implemen-
into account in all phases of data analysis, especially in    tation [39]; the study outcomes may serve, moreover, to
the calculation of the confidence intervals (CI) of the       evaluate this manual.
estimates and in the hypothesis tests:                           In addition, our project seeks to enhance the impor-
  1. Descriptive analysis of each variable with its corre-    tance of multidisciplinary teams working in the design,
sponding CI at 95%. Tests for normality. Description of       implantation and evaluation of CPGs.
losses and quitting.                                             As for the limitations of this study, the design selected
  2. Comparison of the group at the beginning of the          for this project is the best possible given the intervention,
trial with regards to response variables, descriptive vari-   while seeking to avoid possible contamination. Although
ables, and prediction factors. Bivariate statistical tests    the number of clusters is enough for the randomization
will be used suitable to the type of variable (qualitative    to balance the potentially confounding factors among
or quantitative).                                             themselves, the following must be taken into account:
  3. Analysis of primary outcome. There will be a com-           1. Given the nature of the study, the intervention can-
parison of the percentage of patients with a reduction        not be masked.
of two or more points on the Goldberg anxiety sub-               2. There may be a classification bias, given the diffi-
scale at six and twelve months from the intervention in       culty professionals have for making specific diagnoses,
both groups by the chi-squared test, and the confi-           but this should be minimized by the information con-
dence interval of the difference will be calculated. Con-     tained in the guideline.
founding variables will be controlled with multivariate          3. Patients will be enrolled in the study by their own
analysis based on logistic regression with random             professionals. This increases variability in the approach,
effects.                                                      which will be minimized, on the one hand, by the train-
  4. Analysis of secondary outcome. For each of the sec-      ing of all participating professionals and, on the other
ondary response variables the results of the variables        hand, by the protocolization of the research and the
will be compared based on the group assigned by calcu-        implementation of the computer application of the data
lating the difference in proportions of each variable.        collection log in the computer programme. Moreover,
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                          Page 7 of 9
http://www.implementationscience.com/content/6/1/123




 Figure 1 Flowchart.




the fact that the professionals themselves enrol patients      5. There may be a selection bias, because the selection
will increase applicability in regular practice.            and inclusion of patients will take place after randomisa-
  4. Although losses are contemplated in the follow-up,     tion of clusters. In order to be able to evaluate this bias, the
these are reduced in primary care because of the proxi-     information of those persons who decline to participate for
mity of users to the system.                                each intervention group will be collected and compared.
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                                                                  Page 8 of 9
http://www.implementationscience.com/content/6/1/123




  In summary, the main contribution of our project is                              7.    Kroenke K, Spitzer RL, Willians JB, Monahan PO, Löwe B: Anxiety disorders
                                                                                         in primary care: prevalence, impairment, comorbidity, and detection.
that it seeks to identify an effective strategy for imple-                               Ann Intern Med 2007, 6:146(5):317-25.
menting a CPG for the management of a common                                       8.    Pascual JC, Castaño J, Espluga N, Díaz B, Garcia-Ribera C, Bulbena A:
disorder present in primary care. Ensuring the appro-                                    Enfermedades somáticas en pacientes con trastornos de ansiedad. Med
                                                                                         Clin (Barc) 2008, 130(8):281-85.
priate uptake of guideline recommendations can                                     9.    Somers JM, Goldner EM, Waraich P, Hsu L: Prevalence and incidence
reduce clinical variation and improve the care patients                                  studies of anxiety disorders: a systematic review of the literature. Can J
receive.                                                                                 Psychiatry 2006, 51(2):100-113.
                                                                                   10.   Haro JM, Palacín C, Vilagut G, Martinez M, Bernal M, Luque I, Codony M,
                                                                                         Dolz M, Alonso J: Prevalencia de los trastornos mentales y factores
Additional material                                                                      asociados: resultados del estudio ESEMeD-España. Med Clín (Barc.) 2006,
                                                                                         126:445-451.
                                                                                   11.   Estrategia en Salud Mental del Sistema nacional de Salud. Ministerio de
    Additional file 1: CONSORT checklist. Checklist of items to include
                                                                                         Sanidad y Consumo 2006, Disponible en http://www.msc.es.
    when reporting a cluster randomised trial.
                                                                                   12.   Informe del Estado de Salud de la Población de la Comunidad de
                                                                                         Madrid 2007. Dirección General de Salud Pública y Alimentación. Consejería
                                                                                         de Sanidad y Consumo. Comunidad de Madrid 2005.
                                                                                   13.   Informe sobre la Salud en el Mundo 2001. Salud Mental: nuevos
Acknowledgements                                                                         conocimientos, nuevas esperanzas. OMS; 2001.
We would like to thank the methodological support of Unidad de Apoyo a             14.   Hodges B, Inch C, Silver I: Improving the psyquiatric knowledge, skills,
la Investigación, Gerencia de Atención Primaria de Madrid, and Clinical Trials           and attitudes of primary care physicians, 1950-2000: a review. Am J
Support Unit of the Agencia Laín Entralgo of the Community of Madrid.                    Psychiatry 2001, 158:1579-86.
Thanks to Carmen Ferrer Arnedo for facilitating the realization of this project,   15.   Latorre Postigo JM, López-Torres Hidalgo J, Montañés Rodríguez J, Parra
to Esperanza Escortell, Mª Teresa Rodriguez-Monje and Marisol Pato Esteban               Delgado M: Percepción de la demanda y necesidades de formación en
for their contributions to the final version.                                            salud mental de los médicos de atención primaria. Aten Primaria 2005,
                                                                                         36(2):85-92.
Author details                                                                     16.   Stein M, Sherbourne C, Craske M, Means-Christensen A, Bystritsky A,
1
 Centro de Salud El Naranjo. Gerencia Atención Primaria. Servicio Madrileño              Katon W, Sullivan G, Roy-Byrne P: Quality care for primary care patients
de Salud. Spain. 2Unidad Apoyo a la Investigación. Gerencia Atención                     with anxiety disorders. Am J Psychiatry 2004, 161:2230-2237.
Primaria, Servicio Madrileño de Salud, Spain. 3Centro de Salud Castilla La         17.   Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK: Physician office
Nueva. Gerencia Atención Primaria, Servicio Madrileño de Salud, Spain.                   visits of adults for anxiety disorders in the United States 1985-1998. J
4
 Centro de Salud Mª Ángeles López Gómez. Gerencia Atención Primaria,                     Gen Intern Med 2002, 17(3):165-72.
Servicio Madrileño de Salud, Spain. 5Centro de Salud Mendiguchía Carriche.         18.   Guías de Práctica Clínica en el Sistema Nacional de Salud. , Disponible
Gerencia Atención Primaria, Servicio Madrileño de Salud, Spain. 6Centro de               en http://www.guiasalud.es/.
Salud Francia. Gerencia Atención Primaria, Servicio Madrileño de Salud,            19.   Grupo de Trabajo de la GPC para el Manejo de Pacientes con Trastornos
Spain. 7Centro de Salud Humanes. Gerencia Atención Primaria, Servicio                    de Ansiedad en Atención Primaria: Madrid: Plan Nacional para el SNS
Madrileño de Salud, Spain. 8Centro de Salud Santa Isabel. Gerencia Atención              del MSC. Unidad de Evaluación de Tecnologías Sanitarias. Agencia Laín
Primaria, Servicio Madrileño de Salud, Spain. 9Dirección Asistencial Sur.                Entralgo. Comunidad de Madrid 2008, Guías de Práctica Clínica en el SNS:
Gerencia Atención Primaria, Servicio Madrileño de Salud, Spain.                          UETS N° 2006/10.
                                                                                   20.   Demertzis KH, Craske MG: Anxiety in primary care. Curr Psychiatry Rep
Authors’ contributions                                                                   2006, 8:291-297.
ETB conceived the study. ETB, ICG and TSC participated in the design and           21.   Tello ME, Téllez A, Ruiz A, de Frutos MA, Elcano R: Técnicas grupales y
coordination. MLSH, MJPC, MFG, FGM, MJS, SMI, HPF, and CRP collaborated                  relajación en el tratamiento de algunos subtipos de ansiedad: un
in the methodology, the design of the intervention, and the bibliographical              estudio de intervención controlado no aleatorio. Aten Primaria 1997,
search. ETB, ICG, TSC, and FGB wrote the manuscript. All the authors critically          19:67-71.
evaluated the content of this article until the final version was approved.        22.   Bulbena A, Ibarra N, Ballesteros J, y Gago J: Instrumentos de evaluación de
                                                                                         los trastornos mentales en atención primaria. In Psiquiatría en atención
Competing interests                                                                      primaria.. 2 edition. Edited by: Vázquez Barquero JL. Grupo aula médica S.L.;
The authors declare that they have no competing interests.                               2008:107-125.
                                                                                   23.   Badía X, Alonso J: Medidas de bienestar psicológico y salud mental. In La
Received: 30 June 2011 Accepted: 1 December 2011                                         medida de la salud. Guía de escalas de medición en español. Edited by: Badía
Published: 1 December 2011                                                               X, Alonso J. Barcelona; 2007:49-88.
                                                                                   24.   Bulbena A, Bobes J, Luque A, Dal-Ré R, Ballesteros J, Ibarra N, y el Grupo de:
References                                                                               Validación en Español de Escalas Psicométricas (GVEEP): Validación de
1. López-Ibor JJ, Valdés M, editores: DMS-IV-TR-AP. Manual diagnóstico y                 las versiones en español de la Clinical Anxiety Scale y del Physician
    estadístico de los trastornos mentales. Texto revisado. Atención Primaria            Questionnaire para la evaluación de los trastornos de ansiedad. Med Clín
    Barcelona: Masson; 2004.                                                             (Barc) 2003, 121(10):367-374.
2. Tyrer P, Baldwin D: Generalised anxiety disorder. Lancet 2006, 368:2156-66.     25.   Montón C, Pérez-Echeverría MI, Campos R, y cols: Escalas de ansiedad y
3. Hettema JM, Neale MC, Kendler KS: A review and meta-analysis of the                   depresión de Goldberg: una guía de entrevista eficaz para la detección
    genetic epidemiology of anxiety disorders. Am J Psychiatry 2001,                     del malestar psíquico. Aten Primaria 1993, 12(6):345-9.
    158(10):1568-78.                                                               26.   Romero A: Como diseñar un plan de implementación de una guía de
4. Allgulander C: Generalized anxiety disorder: What are we missing? Eur                 práctica clínica. REDEGUIAS-GuiaSalud 2005, Disponible en http://www.
    Neuropsychopharmacol 2006, 16:101-108.                                               guiasalud.es/.
5. Gross C, Hen R: The development origins of anxiety. Nat Rev Neurosci            27.   Implementing clinical practice guidelines. [Monografia en Internet], David D,
    2005, 5:545-552.                                                                     Taylor-Vaisey A: What the literature says: traslating guidelines into
6. McIntosh A, Cohen A, Turnbull N, Esmonde L, Dennis P, Eatock J, Feetam C,             practice Ottawa: Canadian Medical Assotiation. 1997, Disponible en
    Hague J, Hughes I, Kelly J, Krosky N, Lear G, Owens L, Ratcliffe J,                  http://mdm.ca/cpgsnew/cpgs/handbook/sect_2.htm..
    Salkovskys P: Clinical Guidelines and Evidence Review for Panic Disorder       28.   Grol R, Grimshaw J: From best evidence to best practice; about effective
    and Generalised Anxiety Disorder. Sheffeld: University of Sheffeld/London.           implementation of change in patient care. Lancet 2003,
    National Collaborating Centre for Primary Care; 2004, 4.                             362(93919):1225-30.
Tello-Bernabé et al. Implementation Science 2011, 6:123                                                                                       Page 9 of 9
http://www.implementationscience.com/content/6/1/123




29. Grupo de trabajo sobre GPC: Elaboración de Guías de Práctica Clínica en
    el SNS. Manual Metodológico. Madrid: Plan Nacional para el SNS del MSC.
    Instituto Aragonés de Ciencias de la Salud-I+CS; 2007, Guías de Práctica
    Clínica en el SNS: I+CS N° 2006/01.
30. The Cochrane Database, Issue 3, 2004.[base de datos en Internet]. Oxford:
    Update Software Ltd; 1998, Shaw B, Cheater F, Baker R, Gillies C,
    Hearnshaw H, Flottorp S, Robertson N: Tailored interventions to overcome
    identified barriers to change: effects on professional practice and health
    care outcomes., Disponible en: http://www.update-software.com.
31. Babor TF, Higgins-Blide JC: Alcohol screening and brief intervention:
    dissemination strategies for medical practice and public health. Addiction
    2000, 95(5):677-86.
32. Cochrane Effective Practice and Organisation of Care Group (EPOC): The
    Data Collection Checklist. 2009 [http://epoc.cochrane.org/sites/epoc.
    cochrane.org/files/uploads/datacollectionchecklist.pdf], accessed 12 June
    2011.
33. Grimshaw JM, Thomas RE, Maclennan G, Fraser C, Vale L, Whitty P,
    Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C:
    Effectiveness and efficiency of guideline dissemination and
    implementation strategies. Health Technol Asses 2004, 8(6):iii-iv, 1-72.
34. Gomez-Doblas JJ: Implementación de guías clínicas. Rev Esp Cardiol 2006,
    59(Suppl 3):29-35.
35. Alonso P, Bonfill X: Guías de práctica clínica (I): elaboración, implantación
    y evaluación. Radiología 2007, 49(1):19-22.
36. Campbell MJ: Cluster randomized trials in general (family) practice
    research. Stat Methods Med Res 2000, 9:81-94.
37. García-Gutierrez JF, Minué Lorenzo S: Métodos y estrategias para la
    implementación de las guías de práctica clínica (GPC) ¿Cómo hacer que
    las GPC sean efectivas? In Guías de práctica clínica en la asistencia médica
    diaria. Edited by: García-Caballero M. Málaga: Ciencia Biomédica,
    Universidad de Málaga; 2003:.
38. Hutchinson A, McIntosh A, Cox S, Gilbert C: Towars efficient guidelines:
    How to monitor guideline use in primary care. Health Technol Asses 2003,
    7(18):iii, 1-97.
39. Grupo de trabajo sobre implementación de GPC: Implementación de
    Guías de Práctica Clínica del Sistema Nacional de Salud. Manual
    Metodológico. Plan de Calidad para el Sistema Nacional de Salud del
    Ministerio de Sanidad y Política Social. Instituto Aragonés de Ciencias de
    la Salud-I+CS; 2009, Guías de Práctica Clínica en el SNS: I+CS N° 2007/02-02.

 doi:10.1186/1748-5908-6-123
 Cite this article as: Tello-Bernabé et al.: Effectiveness of a clinical
 practice guideline implementation strategy for patients with anxiety
 disorders in primary care: cluster randomized trial. Implementation
 Science 2011 6:123.




                                                                                    Submit your next manuscript to BioMed Central
                                                                                    and take full advantage of:

                                                                                    • Convenient online submission
                                                                                    • Thorough peer review
                                                                                    • No space constraints or color figure charges
                                                                                    • Immediate publication on acceptance
                                                                                    • Inclusion in PubMed, CAS, Scopus and Google Scholar
                                                                                    • Research which is freely available for redistribution


                                                                                    Submit your manuscript at
                                                                                    www.biomedcentral.com/submit

More Related Content

What's hot

Does publication bias inflate the apparent efficacy of psychological treatmen...
Does publication bias inflate the apparent efficacy of psychological treatmen...Does publication bias inflate the apparent efficacy of psychological treatmen...
Does publication bias inflate the apparent efficacy of psychological treatmen...Scott Miller
 
Medication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceMedication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceScott Miller
 
Duration of Psychological Therapy
Duration of Psychological TherapyDuration of Psychological Therapy
Duration of Psychological TherapyScott Miller
 
ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...
ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...
ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...painezeeman
 
NR451_Milestone2_Design_Proposal allen
NR451_Milestone2_Design_Proposal  allenNR451_Milestone2_Design_Proposal  allen
NR451_Milestone2_Design_Proposal allenGary Allen
 
Do therapists improve (preprint)
Do therapists improve (preprint)Do therapists improve (preprint)
Do therapists improve (preprint)Scott Miller
 
Pautas para el manejo del dolor en perros.pdf
Pautas para el manejo del dolor en perros.pdfPautas para el manejo del dolor en perros.pdf
Pautas para el manejo del dolor en perros.pdfDanielBarriga10
 
Bito.s decision aid_template_at_smdm19
Bito.s decision aid_template_at_smdm19Bito.s decision aid_template_at_smdm19
Bito.s decision aid_template_at_smdm19Seiji Bito
 
Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...
Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...
Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...Wendy.J. Seymour
 
2012 poster cost benefice psychotherapy dezetter
2012 poster cost benefice psychotherapy dezetter2012 poster cost benefice psychotherapy dezetter
2012 poster cost benefice psychotherapy dezetterAnne Dezetter
 
PosterPresentations TR in BHU_BB
PosterPresentations TR in BHU_BBPosterPresentations TR in BHU_BB
PosterPresentations TR in BHU_BBBethany Diedrich
 
Case study: limits and potential impact of multidimensional assessment of p...
Case study: limits and potential impact of multidimensional assessment of p...Case study: limits and potential impact of multidimensional assessment of p...
Case study: limits and potential impact of multidimensional assessment of p...HTAi Bilbao 2012
 
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...Vipul Kashyap
 
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)Scott Miller
 
Beyond measures and monitoring
Beyond measures and monitoringBeyond measures and monitoring
Beyond measures and monitoringScott Miller
 
The economic value of monitoring patient treatment response (Lambert, 2014)
The economic value of monitoring patient treatment response (Lambert, 2014)The economic value of monitoring patient treatment response (Lambert, 2014)
The economic value of monitoring patient treatment response (Lambert, 2014)Scott Miller
 

What's hot (20)

Does publication bias inflate the apparent efficacy of psychological treatmen...
Does publication bias inflate the apparent efficacy of psychological treatmen...Does publication bias inflate the apparent efficacy of psychological treatmen...
Does publication bias inflate the apparent efficacy of psychological treatmen...
 
Medication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceMedication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic Alliance
 
Duration of Psychological Therapy
Duration of Psychological TherapyDuration of Psychological Therapy
Duration of Psychological Therapy
 
ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...
ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...
ZMPCZM019000.11.04 Evidenced based guidelines for Migrane Headache : Behaviou...
 
NR451_Milestone2_Design_Proposal allen
NR451_Milestone2_Design_Proposal  allenNR451_Milestone2_Design_Proposal  allen
NR451_Milestone2_Design_Proposal allen
 
Do therapists improve (preprint)
Do therapists improve (preprint)Do therapists improve (preprint)
Do therapists improve (preprint)
 
Quiz on health
Quiz on healthQuiz on health
Quiz on health
 
Pautas para el manejo del dolor en perros.pdf
Pautas para el manejo del dolor en perros.pdfPautas para el manejo del dolor en perros.pdf
Pautas para el manejo del dolor en perros.pdf
 
Bito.s decision aid_template_at_smdm19
Bito.s decision aid_template_at_smdm19Bito.s decision aid_template_at_smdm19
Bito.s decision aid_template_at_smdm19
 
The canine cure.
The canine cure.The canine cure.
The canine cure.
 
Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...
Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...
Malaria prevention,mefloquine neurotoxicity,neuropsychiatric illness,and risk...
 
2012 poster cost benefice psychotherapy dezetter
2012 poster cost benefice psychotherapy dezetter2012 poster cost benefice psychotherapy dezetter
2012 poster cost benefice psychotherapy dezetter
 
PosterPresentations TR in BHU_BB
PosterPresentations TR in BHU_BBPosterPresentations TR in BHU_BB
PosterPresentations TR in BHU_BB
 
Case study: limits and potential impact of multidimensional assessment of p...
Case study: limits and potential impact of multidimensional assessment of p...Case study: limits and potential impact of multidimensional assessment of p...
Case study: limits and potential impact of multidimensional assessment of p...
 
Placement project
Placement projectPlacement project
Placement project
 
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations...
 
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)
 
Beyond measures and monitoring
Beyond measures and monitoringBeyond measures and monitoring
Beyond measures and monitoring
 
The economic value of monitoring patient treatment response (Lambert, 2014)
The economic value of monitoring patient treatment response (Lambert, 2014)The economic value of monitoring patient treatment response (Lambert, 2014)
The economic value of monitoring patient treatment response (Lambert, 2014)
 
J.Clin_.Psychiatry
J.Clin_.PsychiatryJ.Clin_.Psychiatry
J.Clin_.Psychiatry
 

Viewers also liked

13 Προγράμματα C.
13 Προγράμματα C.13 Προγράμματα C.
13 Προγράμματα C.Stathis Gourzis
 
Art experiences and attitude toward art education a descriptive study of miss...
Art experiences and attitude toward art education a descriptive study of miss...Art experiences and attitude toward art education a descriptive study of miss...
Art experiences and attitude toward art education a descriptive study of miss...RozekRuzaini Tajuddin
 
Rynny zambelli
Rynny zambelliRynny zambelli
Rynny zambelliwampirek80
 
3 skill sets for it managers
3   skill sets for it managers3   skill sets for it managers
3 skill sets for it managersKapil Chhabra
 
Mn510 lesson plan_safe_handling_power_point[1]
Mn510 lesson plan_safe_handling_power_point[1]Mn510 lesson plan_safe_handling_power_point[1]
Mn510 lesson plan_safe_handling_power_point[1]Todd Gladden
 

Viewers also liked (11)

Thermo 2
Thermo 2Thermo 2
Thermo 2
 
Diapulse References
Diapulse ReferencesDiapulse References
Diapulse References
 
13 Προγράμματα C.
13 Προγράμματα C.13 Προγράμματα C.
13 Προγράμματα C.
 
Safety Tip - Prevent Overexertion
Safety Tip - Prevent OverexertionSafety Tip - Prevent Overexertion
Safety Tip - Prevent Overexertion
 
Art experiences and attitude toward art education a descriptive study of miss...
Art experiences and attitude toward art education a descriptive study of miss...Art experiences and attitude toward art education a descriptive study of miss...
Art experiences and attitude toward art education a descriptive study of miss...
 
Simpep2010
Simpep2010Simpep2010
Simpep2010
 
Rynny zambelli
Rynny zambelliRynny zambelli
Rynny zambelli
 
Lesson 3
Lesson 3Lesson 3
Lesson 3
 
3 skill sets for it managers
3   skill sets for it managers3   skill sets for it managers
3 skill sets for it managers
 
Produse fm
Produse fmProduse fm
Produse fm
 
Mn510 lesson plan_safe_handling_power_point[1]
Mn510 lesson plan_safe_handling_power_point[1]Mn510 lesson plan_safe_handling_power_point[1]
Mn510 lesson plan_safe_handling_power_point[1]
 

Similar to Efficacia clinica di una strategia terapeutica per pazienti con disturbi d'ansia in primary care: trial randomizzato

efficacy of a dilemma focused intervention for unipolar depression
efficacy of a dilemma focused intervention for unipolar depressionefficacy of a dilemma focused intervention for unipolar depression
efficacy of a dilemma focused intervention for unipolar depressionGuillem Feixas
 
2Annotated Bibliography3164 wordsRough Draft o.docx
2Annotated Bibliography3164 wordsRough Draft o.docx2Annotated Bibliography3164 wordsRough Draft o.docx
2Annotated Bibliography3164 wordsRough Draft o.docxrhetttrevannion
 
Mb managing anxiety_in_practice_april_26
Mb managing anxiety_in_practice_april_26Mb managing anxiety_in_practice_april_26
Mb managing anxiety_in_practice_april_26henkpar
 
Clinical decision making in paedriatic physiotherapy
Clinical decision making in paedriatic physiotherapyClinical decision making in paedriatic physiotherapy
Clinical decision making in paedriatic physiotherapyPOOJAMAHASETH1
 
Adesão terapeutica
Adesão terapeuticaAdesão terapeutica
Adesão terapeuticacarlabastos
 
Low clinical value practices and harm caused by doing what should not be done...
Low clinical value practices and harm caused by doing what should not be done...Low clinical value practices and harm caused by doing what should not be done...
Low clinical value practices and harm caused by doing what should not be done...Javier González de Dios
 
Program Overview
Program OverviewProgram Overview
Program OverviewSara Lancia
 
A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...
A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...
A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...Associate Professor in VSB Coimbatore
 
Mental health assignment (2)
Mental health assignment (2)Mental health assignment (2)
Mental health assignment (2)asma2393
 
Pain in the elderly. How to better understand and rate it.
Pain in the elderly. How to better understand and rate it.Pain in the elderly. How to better understand and rate it.
Pain in the elderly. How to better understand and rate it.Ross Finesmith M.D.
 
Mind Body Practices for Psoriasis-Crimson Publishers
Mind Body Practices for Psoriasis-Crimson PublishersMind Body Practices for Psoriasis-Crimson Publishers
Mind Body Practices for Psoriasis-Crimson PublishersCrismonPublishersCJSH
 
OUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptxOUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptxAsiya Naaz
 
Salud U4 P2
Salud U4 P2Salud U4 P2
Salud U4 P2c.meza
 
Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...
Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...
Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...komalicarol
 
CON 321 Health Related Research.docx
CON 321 Health Related Research.docxCON 321 Health Related Research.docx
CON 321 Health Related Research.docxwrite31
 
Key Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docxKey Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docx4934bk
 
A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...
A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...
A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...BRNSSPublicationHubI
 
Psychosocial interventions for fatigue during cancer treatment with palliativ...
Psychosocial interventions for fatigue during cancer treatment with palliativ...Psychosocial interventions for fatigue during cancer treatment with palliativ...
Psychosocial interventions for fatigue during cancer treatment with palliativ...Maja Miljanović
 

Similar to Efficacia clinica di una strategia terapeutica per pazienti con disturbi d'ansia in primary care: trial randomizzato (20)

efficacy of a dilemma focused intervention for unipolar depression
efficacy of a dilemma focused intervention for unipolar depressionefficacy of a dilemma focused intervention for unipolar depression
efficacy of a dilemma focused intervention for unipolar depression
 
2Annotated Bibliography3164 wordsRough Draft o.docx
2Annotated Bibliography3164 wordsRough Draft o.docx2Annotated Bibliography3164 wordsRough Draft o.docx
2Annotated Bibliography3164 wordsRough Draft o.docx
 
Mb managing anxiety_in_practice_april_26
Mb managing anxiety_in_practice_april_26Mb managing anxiety_in_practice_april_26
Mb managing anxiety_in_practice_april_26
 
Clinical decision making in paedriatic physiotherapy
Clinical decision making in paedriatic physiotherapyClinical decision making in paedriatic physiotherapy
Clinical decision making in paedriatic physiotherapy
 
Adesão terapeutica
Adesão terapeuticaAdesão terapeutica
Adesão terapeutica
 
Low clinical value practices and harm caused by doing what should not be done...
Low clinical value practices and harm caused by doing what should not be done...Low clinical value practices and harm caused by doing what should not be done...
Low clinical value practices and harm caused by doing what should not be done...
 
Article 6
Article 6Article 6
Article 6
 
Program Overview
Program OverviewProgram Overview
Program Overview
 
A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...
A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...
A Study to Assess the Impact of Covid-19 on Stress and Coping Responses among...
 
Mental health assignment (2)
Mental health assignment (2)Mental health assignment (2)
Mental health assignment (2)
 
Pain in the elderly. How to better understand and rate it.
Pain in the elderly. How to better understand and rate it.Pain in the elderly. How to better understand and rate it.
Pain in the elderly. How to better understand and rate it.
 
Mind Body Practices for Psoriasis-Crimson Publishers
Mind Body Practices for Psoriasis-Crimson PublishersMind Body Practices for Psoriasis-Crimson Publishers
Mind Body Practices for Psoriasis-Crimson Publishers
 
OUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptxOUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptx
 
Salud U4 P2
Salud U4 P2Salud U4 P2
Salud U4 P2
 
Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...
Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...
Delirium Care Pathway MoDelirium Care Pathway Model Design: STOP DELIRIUMdel ...
 
Dr. Obumneke Amadi public health epidemiology transcript
Dr. Obumneke Amadi  public health epidemiology transcriptDr. Obumneke Amadi  public health epidemiology transcript
Dr. Obumneke Amadi public health epidemiology transcript
 
CON 321 Health Related Research.docx
CON 321 Health Related Research.docxCON 321 Health Related Research.docx
CON 321 Health Related Research.docx
 
Key Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docxKey Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docx
 
A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...
A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...
A Review of the Issues by Which a Blockchain Solution Could Improve the Preva...
 
Psychosocial interventions for fatigue during cancer treatment with palliativ...
Psychosocial interventions for fatigue during cancer treatment with palliativ...Psychosocial interventions for fatigue during cancer treatment with palliativ...
Psychosocial interventions for fatigue during cancer treatment with palliativ...
 

More from MerqurioEditore_redazione

Stomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamentiStomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamentiMerqurioEditore_redazione
 
Le onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamentoLe onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamentoMerqurioEditore_redazione
 
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità MerqurioEditore_redazione
 
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...MerqurioEditore_redazione
 
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio EditoreGruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio EditoreMerqurioEditore_redazione
 
Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...MerqurioEditore_redazione
 
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...MerqurioEditore_redazione
 
Canali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul webCanali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul webMerqurioEditore_redazione
 
e-Detailing: la comunicazione medico scientifica con efficacia promozional
e-Detailing: la comunicazione medico scientifica  con efficacia promozionale-Detailing: la comunicazione medico scientifica  con efficacia promozional
e-Detailing: la comunicazione medico scientifica con efficacia promozionalMerqurioEditore_redazione
 
Supplemento di ferro e vitamnine in donne anemiche in gravidanza
Supplemento di ferro e vitamnine  in donne anemiche in gravidanzaSupplemento di ferro e vitamnine  in donne anemiche in gravidanza
Supplemento di ferro e vitamnine in donne anemiche in gravidanzaMerqurioEditore_redazione
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaMerqurioEditore_redazione
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaMerqurioEditore_redazione
 
Approcci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsonianaApprocci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsonianaMerqurioEditore_redazione
 
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...MerqurioEditore_redazione
 

More from MerqurioEditore_redazione (20)

Stomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamentiStomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamenti
 
Micosi e amorolfina
Micosi e amorolfinaMicosi e amorolfina
Micosi e amorolfina
 
Antimicotici
AntimicoticiAntimicotici
Antimicotici
 
Il controllo delle micosi gli antifungini
Il controllo delle micosi  gli antifunginiIl controllo delle micosi  gli antifungini
Il controllo delle micosi gli antifungini
 
Le onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamentoLe onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamento
 
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
 
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
 
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio EditoreGruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
 
Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...
 
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
 
Canali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul webCanali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul web
 
e-Detailing: la comunicazione medico scientifica con efficacia promozional
e-Detailing: la comunicazione medico scientifica  con efficacia promozionale-Detailing: la comunicazione medico scientifica  con efficacia promozional
e-Detailing: la comunicazione medico scientifica con efficacia promozional
 
Emostasi
EmostasiEmostasi
Emostasi
 
Emostasi
EmostasiEmostasi
Emostasi
 
Supplemento di ferro e vitamnine in donne anemiche in gravidanza
Supplemento di ferro e vitamnine  in donne anemiche in gravidanzaSupplemento di ferro e vitamnine  in donne anemiche in gravidanza
Supplemento di ferro e vitamnine in donne anemiche in gravidanza
 
Linee guida per la fibrillazione atriale
Linee guida per la fibrillazione atrialeLinee guida per la fibrillazione atriale
Linee guida per la fibrillazione atriale
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
 
Approcci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsonianaApprocci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsoniana
 
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfDr Jeenal Mistry
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...Catherine Liao
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsSavita Shen $i11
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsLanceCatedral
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMeenakshiGursamy
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdfKs doctor
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Catherine Liao
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Catherine Liao
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxdrwaque
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSavita Shen $i11
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadNephroTube - Dr.Gawad
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxgauripg8
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...kevinkariuki227
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...KavyasriPuttamreddy
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Catherine Liao
 

Recently uploaded (20)

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 

Efficacia clinica di una strategia terapeutica per pazienti con disturbi d'ansia in primary care: trial randomizzato

  • 1. Tello-Bernabé et al. Implementation Science 2011, 6:123 http://www.implementationscience.com/content/6/1/123 Implementation Science STUDY PROTOCOL Open Access Effectiveness of a clinical practice guideline implementation strategy for patients with anxiety disorders in primary care: cluster randomized trial Eugenia Tello-Bernabé1*, Teresa Sanz-Cuesta2, Isabel del Cura-González2, María L de Santiago-Hernando3, Montserrat Jurado-Sueiro3, Mercedes Fernández-Girón4, Francisca García-de Blas5, Higinio Pensado-Freire6, Francisco Góngora-Maldonado7, María J de la Puente-Chamorro6, Carmen Rodríguez-Pasamontes8 and Susana Martín-Iglesias9 Abstract Background: Anxiety is a common mental health problem seen in primary care. However, its management in clinical practice varies greatly. Clinical practice guidelines (CPGs) have the potential to reduce variations and improve the care received by patients by promoting interventions of proven benefit. However, uptake and adherence to their recommendations can be low. Method/design: This study involves a community based on cluster randomized trial in primary healthcare centres in the Madrid Region (Spain). The project aims to determine whether the use of implementation strategy (including training session, information, opinion leader, reminders, audit, and feed-back) of CPG for patients with anxiety disorders in primary care is more effective than usual diffusion. The number of patients required is 296 (148 in each arm), all older than 18 years and diagnosed with generalized anxiety disorder, panic disorder, and panic attacks by the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV). They are chosen by consecutive sampling. The main outcome variable is the change in two or more points into Goldberg anxiety scale at six and twelve months. Secondary outcome variables include quality of life (EuroQol 5D), and degree of compliance with the CPG recommendations on treatment, information, and referrals to mental health services. Main effectiveness will be analyzed by comparing the patients percentage improvement on the Goldberg scale between the intervention group and the control group. Logistic regression with random effects will be used to adjust for prognostic factors. Confounding factors or factors that might alter the effect recorded will be taken into account in this analysis. Discussion: There is a need to identify effective implementation strategies for CPG for the management of anxiety disorders present in primary care. Ensuring the appropriate uptake of guideline recommendations can reduce clinical variation and improve the care patients receive. Trial registration: ISRCTN: ISRCTN83365316 Background of unpleasantness and/or somatic symptoms of tension. Normal and pathological anxiety This feeling is normal in the face of certain day-to-day Anxiety is a common mental health problem seen in stressing situations. When it exceeds a certain intensity primary care. Anxiety can be defined as an anticipation or overwhelms a person’s adaptive capacity, anxiety of future harm or misfortune, accompanied by a feeling becomes pathological. Anxiety disorders are a group of illnesses characterized by the presence of worry, excess * Correspondence: mtello.gapm09@salud.madrid.org of fear or dread, tension, or activation that causes a 1 Centro de Salud El Naranjo. Gerencia Atención Primaria. Servicio Madrileño notable uneasiness or a clinically significant deteriora- de Salud. Spain tion of an individual’s activity [1]. Full list of author information is available at the end of the article © 2011 Tello-Bernabé et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 2 of 9 http://www.implementationscience.com/content/6/1/123 The causes of anxiety disorders are not entirely The scope of the CPG covers the diagnosis and man- known, but biological factors, as well as environmental agement of adult patients with generalized anxiety disor- and psychosocial ones, are involved [2-4]. Some authors ders (GAD) and panic disorder (PD), with or without say that it is the interaction of multiple determining fac- agoraphobia, in the context of primary care. tors that favours the appearance of these anxiety disor- Two aspects of this CPG development are worth not- ders [5]. In addition, co-morbidity with other mental ing. The first is the involvement of patients with anxiety disorders, such as mood disorders, is very common disorders in all phases of the development process. The [3-6]. second is that the CPG includes interventions that can The proper diagnosis, treatment, and, in those cases be carried out by the various professionals working in where necessary, appropriate referral of anxiety disor- primary care. These interventions are carried out at the ders to mental health services, is fundamental for effec- primary healthcare centers, mainly by nursing and/or tive clinical management [7,8]. social workers [19]. Likewise, it is worth noting the low utilization of psychological interventions of proven effec- Anxiety as a health problem tiveness [20]. Our group has carried out a study that The prevalence of anxiety disorders varies depending on focuses on the evaluation of the effectiveness of the different epidemiological studies, with prevalence-year intervention groups directed by nurses in patients with and prevalence-life being set at between 10.6% and anxiety in primary care [21]. 16.6% [9]. Data for Spain from the European Study of The Goldberg Anxiety and Depression Scale (GADS) the Epidemiology of Mental Disorders (ESEMeD) esti- has been included in the guideline to evaluate the mate a prevalence-year of 5.1% [10,11]. Mental disorders changes obtained by the various interventions and as a represent a burden for individuals, as well as for families way to provide key questions to guide the clinical inter- and the community. In the case of the community of view. This scale has been chosen because it is brief and Madrid, neuropsychiatric illnesses are confirmed as the easy to manage and interpret [22-24]. The Spanish ver- first cause of adjusted years of life for incapacity [12]. sion has demonstrated its reliability and validity within According to the World Health Organization’s report the ambit of primary care, and it has the right sensitivity on mental health, 20% of all patients attended by pri- (83.1%), specificity (81.8%), and positive predictive value mary care professionals suffer one or more mental dis- (95.3%) [25]. orders. This report recommends that management and treatment be performed as far as possible in primary Strategies to implement CPGs care so as to facilitate access to services for the greatest CPGs will only be useful for professionals and patients if number of people possible [13]. their recommendations are incorporated to regular clini- cal practice. Achieving this is a complex process in Clinical practice guidelines (CPGs) as a tool for the which several factors play a role [26,27]. management of anxiety disorders in primary care To increase the use of the guideline, its distribution The diagnostic and therapeutic approach to these disor- and implementation strategy must be planned very care- ders varies widely. Primary care professionals have dif- fully. As a first step, the identification of the barriers ferent grades of training in the area of mental health, in and facilitating factors, adapting all strategies to the set- psychiatric interview skills, as well as in psychological ting in which the CPGs will be used, is fundamental intervention techniques [14-16]. [28-30]. A study in the United States between 1985 and 1998 Several CPGs implementation strategies have demon- described an increase in the use of psychopharmaceuti- strated their effectiveness. Some authors group these cal medication in primary care visits (38.7% compared interventions depending on whom they are addressed with 54.6%) while, at the same time, it showed a con- to: physicians and patients, communities or the general stant drop in the use of psychological interventions population, or health centres and/or health systems [31]. (6.8% to 2%) in the treatment of anxiety disorders [17]. The Cochrane EPOC (Effective Practice and Organiza- CPGs are a good tool to reduce this variability and tion of Care) group proposes to classify interventions improve evidence informed in the clinical decision-mak- into four categories: professional interventions (such as ing. In Spain, the Ministry of Health and Social Policy distribution of educational materials or educational has put into effect the ‘Guiasalud’ project [18] to draft meetings); financial interventions (such as fee-for-service CPGs. In the framework of this project, the Clinical or prospective payment); organisational interventions Practice Guideline for the Approach to Anxiety Disorders (such as creation of clinical multidisciplinary teams) and in Primary Care has been drafted in coordination with regulatory interventions (any intervention that aims to the Technologies Assessment Unit of the Agencia Lain change health services delivery or costs by regulation or Entralgo [19]. law) [32].
  • 3. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 3 of 9 http://www.implementationscience.com/content/6/1/123 The Grimshaw [33]et al. review evaluates the effec- information proposed in the guideline (oral or written) tiveness and cost of different clinical practice guideline about their disorder. dissemination-implementation organizational strategies. 3. Evaluate the effectiveness of a CPG implementation This study takes into account the impact on profes- strategy for the management of patients with anxiety sionals as well as on patients. It includes 235 studies disorders compared with the regular strategy, measured (between 1966 and 1998) and 309 comparisons. Among as the degree of suitability of referral to mental health the results, it is worth noting that most implementation services, based criteria established in the guideline. strategies improved adherence to CPGs. Simple strate- 4. Describe the professionals’ opinion about the use- gies, such as reminders, increase adherence by 14.1%. fulness of the CPG. The distribution of educational materials improves this 5. Evaluate the effectiveness of a CPG implementation by 8.1%. Educational programmes, almost always as strategy for the management of patients with anxiety components of more complex interventions, improved disorders compared with the regular strategy measured practice by 6%, and audits and feedback by 7%. The as a change in the patient’s quality of life. complexity of the strategies and the mixture of interven- tions did not improve results. In their conclusions, it is Methods/design noted that there is little evidence about which strategies Design of the study can be more effective in each situation. The authors This study is a two-year community, parallel clinical consider that there is a need to develop and validate trial, randomised by clusters, that compares two differ- theoretical models for behavioural change, as well as to ent CPG implementation strategies. The intervention investigate the efficiency of the strategies in the presence will be made on health professionals (physicians, nurses, of different barriers and factors that can modify and social workers) of primary healthcare centres effectiveness. (PHCC) in the region of Madrid, Spain. The randomiza- We consider it fundamental to put into effect organi- tion units will be PHCCs (clusters). The units of analysis zational strategies that will enable us to use the guide- are patients of health professionals (individual level) of line and apply its recommendations, as well as to the PHCCs participating in the study (as a control or measure and evaluate the impact that implementation of intervention) according to the CONSORT checklist the CPGs will have on professionals modifying their (additional file 1). practices, and improving outcomes for patients [34,35]. There are two reasons for using cluster randomised Subjects of the study trials design: to evaluate the group effect of an interven- Subjects older than 18 years of age, who visit primary tion; and to avoid ‘contamination’ across interventions care because of symptoms compatible with anxiety dis- when trial participants are managed within the same orders at PHCCs in the region of Madrid, and those setting. who have been diagnosed with anxiety disorders accord- ing to Statistical Manual of Mental Disorders-IV (DSM- Main objective IV) criteria [1]. The aim of the present work is to determine whether the use of a CPG implementation strategy (including Inclusion criteria training session, information, opinion leader, reminders, Agree to participate in the study and written informed audit, and feed-back) for patients with anxiety disorders consent. in primary care is more effective than usual diffusion in improving the score of the Goldberg anxiety scale at six Exclusion criteria and twelve months. 1. Subjects diagnosed with anxiety for post-traumatic stress, acute stress disorders, anxiety disorders induced Secondary objectives by substances, organic anxiety disorders. 1. Evaluate the effectiveness of a CPG implementation 2. Subjects who cannot read or understand Spanish. strategy for the management of patients with anxiety 3. Subjects who will not reside in the basic area in the disorders compared with the regular strategy, measured year following their inclusion in the study. as the degree of suitability of the treatments (psycholo- 4. Immobilized or institutionalized patients. gical, pharmacological, et al.) received by patients. 2. Evaluate the effectiveness of a CPG implementation Sample size strategy for the management of patients with anxiety Method of calculation disorders compared with the regular strategy, measured For an alpha of 0,05, a power of 80% and in order to as the percentage of patients who have received the detect a decrease in the Goldberg Scale (two or more
  • 4. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 4 of 9 http://www.implementationscience.com/content/6/1/123 points) of 20% in the intervention group, the overall Intervention group simple size required 206 patients (103 in each arm of The intervention, through the different strategies, has the study). Because randomisation was by cluster, the been designed to allow professionals to understand the sample size had to be larger than if simple randomisa- guideline thoroughly, and also to implement its tion had been performed, in order to take into account recommendations. the design effect (DE). The DE was calculated as follows: 1. The CPG will be searchable on the intranet cor- DE = 1 + (nc - 1) * ICC (where nc is the mean number porative system. of individuals in the cluster, and ICC the intracluster 2. Centralized area clinical session with a duration of correlation coefficient) [36]. The ICC in the present 60 minutes, to which each one of the professionals from work was deemed to be 0.01. The mean cluster size was each of the 16 PHCCs will be invited and where the assumed to be 20 patients. Given these assumptions, CPG will be presented. and expecting a 20% loss rate, the final sample size 3. Information: Presentation of CPG in the PHCCs. required was 296 patients (148 in each arm). 4. Training: two sessions with a duration of 60 min- utes, imparted at PHCCs by the researchers. Randomisation 5. Information and training to physicians, nurses, and Unit of allocation social workers with the following contents: Allocation will be performed by clusters, the PHCC being the randomisation unit. This will minimise possi- a. Information and diagnosis: This would focus on ble contamination effects between professionals. the questions in the guideline that approach the definition of anxiety and its differentiation as a Sequence generation symptom and as a disorder. It would approach the The 16 PHCCs will be assigned to the intervention or semi-structured interview at the visit with an active the control group following a simple, computer-gener- methodology (roll-playing, et al.). ated random sequence (EPIDAT 3.1). b. Pharmacological treatment and algorithms. c. Non-pharmacological treatment: Group techni- Concealment of allocation ques (see table 2), bibliotherapy and medicinal herbs. Randomization will be performed centrally by a researcher not involved in the study, and who was blind 2. Opinion head/leader: a professional designated at to the identity of the PHCCs. each centre (physician, nurse or social worker). Consecutive patients will be chosen to minimise the 3. Structured training: Training of nurses and social risk of bias in their selection. During consultations, workers to carry out anxiety disorder groups of six to patients will be informed about the study and asked eight sessions. whether they would like to take part in it. Those who 4. Reminders: Reminders will be sent in the form of accept will be asked to complete a signed consent form. letters or electronic flashes or systems of alert about Checks will be made to ensure they met all inclusion publications. criteria, but no exclusion criterion. 5. Audit: The results will be audited and will be returned to the PHCCs through the local leader. Masking In the study, the patients, the professionals implement- Patient variables (individual level) ing the interventions, and those assessing the outcomes Variables to measure health outcomes will not be blinded to the assignment group. However, 1. Degree of anxiety, measured by the Goldberg anxiety analysis data will be performed by independent profes- subscale. The decrease in the score by two or more sionals blinded to the assignment group. points compared with baseline score will be evaluated at six and twelve months. Intervention (see Table 1) 2. Quality of life measured by means of the EuroQol Control group 5D questionnaire. The quality of life will be evaluated at 1. The CPGs will be searchable on the intranet corpora- baseline, six months and twelve months. tive system. 2. Centralized area clinical session with a duration of Clinical variables recorded to check the degree of 60 minutes, to which each one of the professionals from suitability of the guideline recommendations each of the 16 health centres will be invited, and where Previous episodes and treatment, diagnosis and current the CPGs will be presented. therapeutic plan, and reason for referral to mental health.
  • 5. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 5 of 9 http://www.implementationscience.com/content/6/1/123 Table 1 Interventions to professionals in both groups Step 1 Centralized clinical session for the 16 PHCCs in which the GPC will be presented. Website ‘Guiasalud’. Invitation to participate. Step 2 Primary Healthcare Centre RANDOMIZATION Step 3 Intervention group Control group IMPLEMENTATION STRATEGIES: Regular care - Information and training about diagnosis and therapeutic plan - Election of opinion leader - Information and training structured to create anxiety disorder groups Step 4 (after visit 2) IMPLEMENTATION STRATEGIES: Regular care - Audit and feedback - Reminders Step 5 (after visit 3) IMPLEMENTATION STRATEGIES: Regular care - Audit and feedback - Reminders Table 2 Group intervention in anxiety First session Presentation of the group General introduction to program Educational component: • What is the response to anxiety? • Why does it happen in daily life? • Is recovery possible? • What is the recovery process? The role of lifestyle in the response to anxiety (Part 1): • What do we do to take care of ourselves? • How lifestyle influences. • Introduction to relaxation and breathing. Second session Introduction, we clarify doubts. The interpretation of body sensations. What is an anxiety crisis? Why does it appear? Understand the role thoughts-behaviour-emotions play in the maintenance of the problem. The role of lifestyle in the response to anxiety (Part 2): • Physical exercise • We learn to breath (control of breathing) • Relaxation training Third session We review relaxation training execution and follow up with respect to exercise. The role of lifestyle in the response to anxiety (Part 3): • Eating/consumption toxics/stimulants • Control of breathing • Relaxation training Fourth session We review relaxation training execution and follow up with respect to exercise. The role of lifestyle in the response to anxiety (Part 4): • Pace activity/rest (sleep) • Control of breathing • Relaxation training Fifth session We review control of breathing and relaxation training execution. Sixth session We review control of breathing and relaxation training execution. Using what we learned to face future changes: integrating vision to remember what we learned. Depending on availability, the group intervention can be extended to eight sessions.
  • 6. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 6 of 9 http://www.implementationscience.com/content/6/1/123 Sociodemographic variables recorded Ethical considerations Age, gender, nationality, time of residence in Spain, and The study protocol was approved by the Research Ethics employment status. Committee on 29 April 2010 and met all good clinical practice demands right. This study has been funded by Variables recorded for family physicians (cluster level) the Spanish Ministry of Science and Innovation via the Age, gender, years of professional activity, training in Instituto de Salud Carlos III (PI09/90304). The trial was interview skills, training in psychological intervention registered with Current Controlled Trials, number techniques, average number of patients attended in ISRCTN83365316. three months, and evaluation about usefulness of the [http://www.controlled-trials.com/ISRCTN83365316] guide and modification of its clinical practice. Discussion Data collection method The proposed implementation strategy should have Professionals impact at four levels: increasing the knowledge of clinical Data will be collected by telephone interview by a mem- physicians and patients; changing attitudes; changing the ber of the research team before randomisation. All data habits and behaviour of professionals in their clinical prac- will be collected except the number of patients visited, tice, while taking into account the patient’s preferences, as which will be taken from the health information system. well as administrative and economic influences; and modi- Opinion will be collected at the end of the study. fying results, which means improving the quality of care and, finally, the health of the population by following CPG Patients recommendations [37,38]. In this study, we will focus on The clinical interview will be used and the data will be checking the degree of suitability of the guideline recom- recorded in an electronic data collection log especially mendations (in terms of treatment, referral to mental designed for this study. The different variables will be health services, and information to the patient) in the clin- collected over four follow-up visits: baseline, three, six, ical practice. We will also check if health outcomes (anxi- and twelve months. The Figure 1 shows the flowchart of ety and quality of life) are improving. the study. If the intervention proposed is effective, it could be generalized to other common problems present in pri- Statistical analysis mary care. The findings of the study can also inform a This will be based on the principle of intention to treat. future updates of the guideline. The ‘Guiasalud’ project The use of the design by clusters chosen will be taken includes a methodological manual for GPCs implemen- into account in all phases of data analysis, especially in tation [39]; the study outcomes may serve, moreover, to the calculation of the confidence intervals (CI) of the evaluate this manual. estimates and in the hypothesis tests: In addition, our project seeks to enhance the impor- 1. Descriptive analysis of each variable with its corre- tance of multidisciplinary teams working in the design, sponding CI at 95%. Tests for normality. Description of implantation and evaluation of CPGs. losses and quitting. As for the limitations of this study, the design selected 2. Comparison of the group at the beginning of the for this project is the best possible given the intervention, trial with regards to response variables, descriptive vari- while seeking to avoid possible contamination. Although ables, and prediction factors. Bivariate statistical tests the number of clusters is enough for the randomization will be used suitable to the type of variable (qualitative to balance the potentially confounding factors among or quantitative). themselves, the following must be taken into account: 3. Analysis of primary outcome. There will be a com- 1. Given the nature of the study, the intervention can- parison of the percentage of patients with a reduction not be masked. of two or more points on the Goldberg anxiety sub- 2. There may be a classification bias, given the diffi- scale at six and twelve months from the intervention in culty professionals have for making specific diagnoses, both groups by the chi-squared test, and the confi- but this should be minimized by the information con- dence interval of the difference will be calculated. Con- tained in the guideline. founding variables will be controlled with multivariate 3. Patients will be enrolled in the study by their own analysis based on logistic regression with random professionals. This increases variability in the approach, effects. which will be minimized, on the one hand, by the train- 4. Analysis of secondary outcome. For each of the sec- ing of all participating professionals and, on the other ondary response variables the results of the variables hand, by the protocolization of the research and the will be compared based on the group assigned by calcu- implementation of the computer application of the data lating the difference in proportions of each variable. collection log in the computer programme. Moreover,
  • 7. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 7 of 9 http://www.implementationscience.com/content/6/1/123 Figure 1 Flowchart. the fact that the professionals themselves enrol patients 5. There may be a selection bias, because the selection will increase applicability in regular practice. and inclusion of patients will take place after randomisa- 4. Although losses are contemplated in the follow-up, tion of clusters. In order to be able to evaluate this bias, the these are reduced in primary care because of the proxi- information of those persons who decline to participate for mity of users to the system. each intervention group will be collected and compared.
  • 8. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 8 of 9 http://www.implementationscience.com/content/6/1/123 In summary, the main contribution of our project is 7. Kroenke K, Spitzer RL, Willians JB, Monahan PO, Löwe B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. that it seeks to identify an effective strategy for imple- Ann Intern Med 2007, 6:146(5):317-25. menting a CPG for the management of a common 8. Pascual JC, Castaño J, Espluga N, Díaz B, Garcia-Ribera C, Bulbena A: disorder present in primary care. Ensuring the appro- Enfermedades somáticas en pacientes con trastornos de ansiedad. Med Clin (Barc) 2008, 130(8):281-85. priate uptake of guideline recommendations can 9. Somers JM, Goldner EM, Waraich P, Hsu L: Prevalence and incidence reduce clinical variation and improve the care patients studies of anxiety disorders: a systematic review of the literature. Can J receive. Psychiatry 2006, 51(2):100-113. 10. Haro JM, Palacín C, Vilagut G, Martinez M, Bernal M, Luque I, Codony M, Dolz M, Alonso J: Prevalencia de los trastornos mentales y factores Additional material asociados: resultados del estudio ESEMeD-España. Med Clín (Barc.) 2006, 126:445-451. 11. Estrategia en Salud Mental del Sistema nacional de Salud. Ministerio de Additional file 1: CONSORT checklist. Checklist of items to include Sanidad y Consumo 2006, Disponible en http://www.msc.es. when reporting a cluster randomised trial. 12. Informe del Estado de Salud de la Población de la Comunidad de Madrid 2007. Dirección General de Salud Pública y Alimentación. Consejería de Sanidad y Consumo. Comunidad de Madrid 2005. 13. Informe sobre la Salud en el Mundo 2001. Salud Mental: nuevos Acknowledgements conocimientos, nuevas esperanzas. OMS; 2001. We would like to thank the methodological support of Unidad de Apoyo a 14. Hodges B, Inch C, Silver I: Improving the psyquiatric knowledge, skills, la Investigación, Gerencia de Atención Primaria de Madrid, and Clinical Trials and attitudes of primary care physicians, 1950-2000: a review. Am J Support Unit of the Agencia Laín Entralgo of the Community of Madrid. Psychiatry 2001, 158:1579-86. Thanks to Carmen Ferrer Arnedo for facilitating the realization of this project, 15. Latorre Postigo JM, López-Torres Hidalgo J, Montañés Rodríguez J, Parra to Esperanza Escortell, Mª Teresa Rodriguez-Monje and Marisol Pato Esteban Delgado M: Percepción de la demanda y necesidades de formación en for their contributions to the final version. salud mental de los médicos de atención primaria. Aten Primaria 2005, 36(2):85-92. Author details 16. Stein M, Sherbourne C, Craske M, Means-Christensen A, Bystritsky A, 1 Centro de Salud El Naranjo. Gerencia Atención Primaria. Servicio Madrileño Katon W, Sullivan G, Roy-Byrne P: Quality care for primary care patients de Salud. Spain. 2Unidad Apoyo a la Investigación. Gerencia Atención with anxiety disorders. Am J Psychiatry 2004, 161:2230-2237. Primaria, Servicio Madrileño de Salud, Spain. 3Centro de Salud Castilla La 17. Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK: Physician office Nueva. Gerencia Atención Primaria, Servicio Madrileño de Salud, Spain. visits of adults for anxiety disorders in the United States 1985-1998. J 4 Centro de Salud Mª Ángeles López Gómez. Gerencia Atención Primaria, Gen Intern Med 2002, 17(3):165-72. Servicio Madrileño de Salud, Spain. 5Centro de Salud Mendiguchía Carriche. 18. Guías de Práctica Clínica en el Sistema Nacional de Salud. , Disponible Gerencia Atención Primaria, Servicio Madrileño de Salud, Spain. 6Centro de en http://www.guiasalud.es/. Salud Francia. Gerencia Atención Primaria, Servicio Madrileño de Salud, 19. Grupo de Trabajo de la GPC para el Manejo de Pacientes con Trastornos Spain. 7Centro de Salud Humanes. Gerencia Atención Primaria, Servicio de Ansiedad en Atención Primaria: Madrid: Plan Nacional para el SNS Madrileño de Salud, Spain. 8Centro de Salud Santa Isabel. Gerencia Atención del MSC. Unidad de Evaluación de Tecnologías Sanitarias. Agencia Laín Primaria, Servicio Madrileño de Salud, Spain. 9Dirección Asistencial Sur. Entralgo. Comunidad de Madrid 2008, Guías de Práctica Clínica en el SNS: Gerencia Atención Primaria, Servicio Madrileño de Salud, Spain. UETS N° 2006/10. 20. Demertzis KH, Craske MG: Anxiety in primary care. Curr Psychiatry Rep Authors’ contributions 2006, 8:291-297. ETB conceived the study. ETB, ICG and TSC participated in the design and 21. Tello ME, Téllez A, Ruiz A, de Frutos MA, Elcano R: Técnicas grupales y coordination. MLSH, MJPC, MFG, FGM, MJS, SMI, HPF, and CRP collaborated relajación en el tratamiento de algunos subtipos de ansiedad: un in the methodology, the design of the intervention, and the bibliographical estudio de intervención controlado no aleatorio. Aten Primaria 1997, search. ETB, ICG, TSC, and FGB wrote the manuscript. All the authors critically 19:67-71. evaluated the content of this article until the final version was approved. 22. Bulbena A, Ibarra N, Ballesteros J, y Gago J: Instrumentos de evaluación de los trastornos mentales en atención primaria. In Psiquiatría en atención Competing interests primaria.. 2 edition. Edited by: Vázquez Barquero JL. Grupo aula médica S.L.; The authors declare that they have no competing interests. 2008:107-125. 23. Badía X, Alonso J: Medidas de bienestar psicológico y salud mental. In La Received: 30 June 2011 Accepted: 1 December 2011 medida de la salud. Guía de escalas de medición en español. Edited by: Badía Published: 1 December 2011 X, Alonso J. Barcelona; 2007:49-88. 24. Bulbena A, Bobes J, Luque A, Dal-Ré R, Ballesteros J, Ibarra N, y el Grupo de: References Validación en Español de Escalas Psicométricas (GVEEP): Validación de 1. López-Ibor JJ, Valdés M, editores: DMS-IV-TR-AP. Manual diagnóstico y las versiones en español de la Clinical Anxiety Scale y del Physician estadístico de los trastornos mentales. Texto revisado. Atención Primaria Questionnaire para la evaluación de los trastornos de ansiedad. Med Clín Barcelona: Masson; 2004. (Barc) 2003, 121(10):367-374. 2. Tyrer P, Baldwin D: Generalised anxiety disorder. Lancet 2006, 368:2156-66. 25. Montón C, Pérez-Echeverría MI, Campos R, y cols: Escalas de ansiedad y 3. Hettema JM, Neale MC, Kendler KS: A review and meta-analysis of the depresión de Goldberg: una guía de entrevista eficaz para la detección genetic epidemiology of anxiety disorders. Am J Psychiatry 2001, del malestar psíquico. Aten Primaria 1993, 12(6):345-9. 158(10):1568-78. 26. Romero A: Como diseñar un plan de implementación de una guía de 4. Allgulander C: Generalized anxiety disorder: What are we missing? Eur práctica clínica. REDEGUIAS-GuiaSalud 2005, Disponible en http://www. Neuropsychopharmacol 2006, 16:101-108. guiasalud.es/. 5. Gross C, Hen R: The development origins of anxiety. Nat Rev Neurosci 27. Implementing clinical practice guidelines. [Monografia en Internet], David D, 2005, 5:545-552. Taylor-Vaisey A: What the literature says: traslating guidelines into 6. McIntosh A, Cohen A, Turnbull N, Esmonde L, Dennis P, Eatock J, Feetam C, practice Ottawa: Canadian Medical Assotiation. 1997, Disponible en Hague J, Hughes I, Kelly J, Krosky N, Lear G, Owens L, Ratcliffe J, http://mdm.ca/cpgsnew/cpgs/handbook/sect_2.htm.. Salkovskys P: Clinical Guidelines and Evidence Review for Panic Disorder 28. Grol R, Grimshaw J: From best evidence to best practice; about effective and Generalised Anxiety Disorder. Sheffeld: University of Sheffeld/London. implementation of change in patient care. Lancet 2003, National Collaborating Centre for Primary Care; 2004, 4. 362(93919):1225-30.
  • 9. Tello-Bernabé et al. Implementation Science 2011, 6:123 Page 9 of 9 http://www.implementationscience.com/content/6/1/123 29. Grupo de trabajo sobre GPC: Elaboración de Guías de Práctica Clínica en el SNS. Manual Metodológico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la Salud-I+CS; 2007, Guías de Práctica Clínica en el SNS: I+CS N° 2006/01. 30. The Cochrane Database, Issue 3, 2004.[base de datos en Internet]. Oxford: Update Software Ltd; 1998, Shaw B, Cheater F, Baker R, Gillies C, Hearnshaw H, Flottorp S, Robertson N: Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes., Disponible en: http://www.update-software.com. 31. Babor TF, Higgins-Blide JC: Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction 2000, 95(5):677-86. 32. Cochrane Effective Practice and Organisation of Care Group (EPOC): The Data Collection Checklist. 2009 [http://epoc.cochrane.org/sites/epoc. cochrane.org/files/uploads/datacollectionchecklist.pdf], accessed 12 June 2011. 33. Grimshaw JM, Thomas RE, Maclennan G, Fraser C, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C: Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Asses 2004, 8(6):iii-iv, 1-72. 34. Gomez-Doblas JJ: Implementación de guías clínicas. Rev Esp Cardiol 2006, 59(Suppl 3):29-35. 35. Alonso P, Bonfill X: Guías de práctica clínica (I): elaboración, implantación y evaluación. Radiología 2007, 49(1):19-22. 36. Campbell MJ: Cluster randomized trials in general (family) practice research. Stat Methods Med Res 2000, 9:81-94. 37. García-Gutierrez JF, Minué Lorenzo S: Métodos y estrategias para la implementación de las guías de práctica clínica (GPC) ¿Cómo hacer que las GPC sean efectivas? In Guías de práctica clínica en la asistencia médica diaria. Edited by: García-Caballero M. Málaga: Ciencia Biomédica, Universidad de Málaga; 2003:. 38. Hutchinson A, McIntosh A, Cox S, Gilbert C: Towars efficient guidelines: How to monitor guideline use in primary care. Health Technol Asses 2003, 7(18):iii, 1-97. 39. Grupo de trabajo sobre implementación de GPC: Implementación de Guías de Práctica Clínica del Sistema Nacional de Salud. Manual Metodológico. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Instituto Aragonés de Ciencias de la Salud-I+CS; 2009, Guías de Práctica Clínica en el SNS: I+CS N° 2007/02-02. doi:10.1186/1748-5908-6-123 Cite this article as: Tello-Bernabé et al.: Effectiveness of a clinical practice guideline implementation strategy for patients with anxiety disorders in primary care: cluster randomized trial. Implementation Science 2011 6:123. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit